Status:

COMPLETED

Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

American Academy of Pediatrics

Conditions:

Influenza

Vaccination

Eligibility:

All Genders

6-8 years

Phase:

NA

Brief Summary

This multi-site study assesses the impact of text message reminders on the receipt of the second dose of influenza vaccine, and takes place primarily in practices from the American Academy of Pediatri...

Detailed Description

The study is to be conducted over the 1st season (September 2017-April 2018) as an effectiveness trial and the 2nd (September 2018-April 2019) as a replication study. This approach tests that the inte...

Eligibility Criteria

Inclusion

  • Parenting adult (or legal guardian) of a child that:
  • is between 6 months through 8 years at the time of enrollment (or the age for which 2 doses of influenza are recommended should Centers for Disease Control and Prevention (CDC) recommendations change)
  • received 1st dose of influenza vaccine within last 7 days
  • receives care at study site
  • needs 2 doses of influenza vaccine that season as determined by their clinician at the study site
  • plan to continue to receive care through April 30 of that season (to the best of their knowledge) (season 2017-18 only)
  • Ability to speak and read English or Spanish
  • Has a cell phone that has text message capability

Exclusion

  • Parenting adult of a child that:
  • already enrolled in the study in this or the previous season
  • will leave practice before end of season (April 30) (to their best knowledge) (2017-18 season only)
  • Was told by a health care provider that child should not get the flu shot again due to an allergic reaction or anaphylaxis (2017-18 season only)
  • Unable to speak and read English or speak and read Spanish
  • Unable to receive or read text messages on their cell phone

Key Trial Info

Start Date :

October 6 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2019

Estimated Enrollment :

2105 Patients enrolled

Trial Details

Trial ID

NCT03287830

Start Date

October 6 2017

End Date

April 30 2019

Last Update

September 15 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

American Academy of Pediatrics

Itasca, Illinois, United States, 60143

2

Columbia University Medical Center

New York, New York, United States, 10032

3

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104